{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:07:31Z","timestamp":1773306451975,"version":"3.50.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The purpose of this review is to summarize recent research regarding the diagnosis of allergic rashes and to suggest future directions for the promotion of accurate diagnosis and endotype specification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Multiple cohort studies demonstrate that with appropriate clinical evaluation, drug allergy labels can be removed in up to 90% of cases. Genetic tests can predict severe adverse cutaneous drug reactions in some cases and in vitro tests are being sought to identify causative drugs in others. Biomarkers to define endotypes of atopic dermatitis are needed to predict which patients will benefit from evolving targeted therapies. Hyperspectral imaging is a rapidly evolving technology in medical diagnostics; additional research is needed to demonstrate whether this promising technology can be used to distinguish allergic rashes and\/or endotypes in atopic dermatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Diagnostic tools for the assessment of allergic rashes are primitive in that they frequently rely on challenges to ascertain whether suspected allergens were causative. Validated in vitro tests with high sensitivity and specificity for drug allergies would benefit the field, particularly in delayed type reactions, as would identification of any hyperspectral signatures that could identify endotypes in atopic dermatitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000489","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T14:48:35Z","timestamp":1489848515000},"page":"371-378","source":"Crossref","is-referenced-by-count":3,"title":["Rash diagnostics: an update on the diagnosis of allergic rashes"],"prefix":"10.1097","volume":"29","author":[{"given":"Corinne Savides","family":"Happel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","article-title":"Improving diagnosis in healthcare","year":"2105"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/cea.12596","article-title":"Utility of skin testing in children with a history of nonimmediate reactions to amoxicillin","volume":"45","author":"Barni","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/pai.12493","article-title":"Direct oral provocation tests in nonimmediate mild cutaneous reactions related to beta-lactam antibiotics","volume":"27","author":"Vezir","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaip.2014.11.001","article-title":"Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions","volume":"3","author":"Mori","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaip.2014.11.002","article-title":"Improving the effectiveness of penicillin allergy de-labeling","volume":"3","author":"Bourke","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000443830","article-title":"Proven nonbeta-lactam antibiotic allergy in children","volume":"169","author":"Guvenir","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J Dermatol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"h4848","DOI":"10.1136\/bmj.h4848","article-title":"Use of HLA-B\u221758:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study","volume":"351","author":"Ko","year":"2015","journal-title":"BMJ"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"e0156000","DOI":"10.1371\/journal.pone.0156000","article-title":"Genome-wide association study in immunocompetent patients with delayed hypersensitivity to sulfonamide antimicrobials","volume":"11","author":"Reinhart","year":"2016","journal-title":"PLoS One"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12016-015-8491-x","article-title":"Eosinophilic drug allergy","volume":"50","author":"Kuruvilla","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1111\/ijd.13126","article-title":"Adverse cutaneous drug reactions in a single quaternary referral hospital","volume":"55","author":"Botelho","year":"2016","journal-title":"Int J Dermatol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1111\/ajd.12347","article-title":"Progression of drug exanthemas to serious drug eruptions: A retrospective review identifying early determinants","volume":"57","author":"Manriquez","year":"2016","journal-title":"Australas J Dermatol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cea.12468","article-title":"Management of allergy to penicillins and other beta-lactams","volume":"45","author":"Mirakian","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjd.14492","article-title":"Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons","volume":"175","author":"Lehloenya","year":"2016","journal-title":"Br J Dermatol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000448284","article-title":"Evaluation of lymphocyte transformation test results in patients with delayed hypersensitivity reactions following the use of anticonvulsant drugs","volume":"170","author":"Karami","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/ijd.13306","article-title":"The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions","volume":"55","author":"Hassoun-Kheir","year":"2016","journal-title":"Int J Dermatol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diagmicrobio.2015.03.008","article-title":"Drug-induced lymphocyte stimulation test in the prediction of drug-induced hypersensitivity to antituberculosis drugs","volume":"82","author":"Sun","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R22-20230918","article-title":"Detection of drug-responsive B lymphocytes and antidrug IgG in patients with beta-lactam hypersensitivity","author":"Amali","year":"2016","journal-title":"Allergy"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bjd.14701","article-title":"In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions","volume":"175","author":"Klaewsongkram","year":"2016","journal-title":"Br J Dermatol"},{"issue":"(3 Suppl)","key":"R24-20230918","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaip.2015.02.009","article-title":"Contact dermatitis: a practice parameter-update 2015","volume":"3","author":"Fonacier","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2133.2007.08412.x","article-title":"Diagnostic criteria for atopic dermatitis: a systematic review","volume":"158","author":"Brenninkmeijer","year":"2008","journal-title":"Br J Dermatol"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/all.12959","article-title":"Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review","volume":"72","author":"Gerbens","year":"2016","journal-title":"Allergy"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12887-016-0607-9","article-title":"Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis","volume":"16","author":"Siegfried","year":"2016","journal-title":"BMC Pediatr"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1542\/peds.2014-1990","article-title":"Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial","volume":"135","author":"Sigurgeirsson","year":"2015","journal-title":"Pediatrics"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1542\/peds.2015-2785A","article-title":"A Critical appraisal of the PETITE study report: topical corticosteroids are safe and effective in the long-term treatment of infantile atopic dermatitis","volume":"136","author":"Weidinger","year":"2015","journal-title":"Pediatrics"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","article-title":"Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults","volume":"75","author":"Paller","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","article-title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial","volume":"387","author":"Thaci","year":"2016","journal-title":"Lancet"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","article-title":"Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)","volume":"75","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.iac.2016.08.003","article-title":"Wet wrap therapy in moderate to severe atopic dermatitis","volume":"37","author":"Nicol","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MOP.0000000000000374","article-title":"Clinical implications of new mechanistic insights into atopic dermatitis","volume":"28","author":"Leung","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2016.07.047","article-title":"Ustekinumab treatment in severe atopic dermatitis: down-regulation of T-helper 2\/22 expression","volume":"76","author":"Weiss","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/exd.13112","article-title":"Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"26","author":"Khattri","year":"2017","journal-title":"Exp Dermatol"},{"key":"R40-20230918","article-title":"Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients","author":"Nic Dhonncha","year":"2016","journal-title":"Br J Dermatol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jdv.12918","article-title":"Inadequate response to ustekinumab in atopic dermatitis: a report of two patients","volume":"30","author":"Samorano","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14207","article-title":"The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study","volume":"174","author":"Nemoto","year":"2016","journal-title":"Br J Dermatol"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ni.3614","article-title":"The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin","volume":"18","author":"Hidaka","year":"2017","journal-title":"Nat Immunol"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.iac.2016.08.008","article-title":"Current and future biomarkers in atopic dermatitis","volume":"37","author":"Thijs","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","article-title":"Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"137","author":"Muraro","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"279ra39","DOI":"10.1126\/scitranslmed.3010302","article-title":"Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells","volume":"7","author":"Watanabe","year":"2015","journal-title":"Sci Transl Med"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.iac.2016.08.013","article-title":"Cutaneous manifestation of food allergy","volume":"37","author":"Tam","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2016.08.016","article-title":"Atopic dermatitis and allergic urticaria: cutaneous manifestations of immunodeficiency","volume":"37","author":"Gaudinski","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pcl.2016.08.004","article-title":"Eczema and urticaria as manifestations of undiagnosed and rare diseases","volume":"64","author":"Youssef","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1117\/1.JBO.19.1.010901","article-title":"Medical hyperspectral imaging: a review","volume":"19","author":"Lu","year":"2014","journal-title":"J Biomed Opt"},{"key":"R51-20230918","article-title":"Hyperspectral imaging in detecting dermal invasion in lentigo maligna melanoma","author":"Neittaanmaki","year":"2016","journal-title":"Br J Dermatol"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.saa.2016.09.034","article-title":"Hyperspectral Raman imaging of human prostatic cells: an attempt to differentiate normal and malignant cell lines by univariate and multivariate data analysis","volume":"173","author":"Musto","year":"2017","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"R53-20230918","first-page":"9788","article-title":"Hyperspectral imaging of neoplastic progression in a mouse model of oral carcinogenesis","author":"Lu","year":"2016","journal-title":"Proc SPIE Int Soc Opt Eng"},{"key":"R54-20230918","first-page":"3925","article-title":"Integrated endoscopic system based on optical imaging and hyperspectral data analysis for colorectal cancer detection","volume":"36","author":"Kumashiro","year":"2016","journal-title":"Anticancer Res"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1088\/0967-3334\/37\/11\/2064","article-title":"Oxygenation and perfusion monitoring with a hyperspectral camera system for chemical based tissue analysis of skin and organs","volume":"37","author":"Holmer","year":"2016","journal-title":"Physiol Meas"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"e0167760","DOI":"10.1371\/journal.pone.0167760","article-title":"Seeing the invisible: revealing atrial ablation lesions using hyperspectral imaging approach","volume":"11","author":"Muselimyan","year":"2016","journal-title":"PLoS One"},{"issue":"(Suppl 1)","key":"R57-20230918","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1097\/IAE.0000000000001325","article-title":"Hyperspectral autofluorescence imaging of drusen and retinal pigment epithelium in donor eyes with age-related macular degeneration","volume":"36","author":"Tong","year":"2016","journal-title":"Retina"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0003702816659667","article-title":"An analysis of human dorsal hand skin texture using hyperspectral imaging technique for assessing the skin aging process","volume":"71","author":"Calin","year":"2017","journal-title":"Appl Spectrosc"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1111\/j.1600-0846.2012.00622.x","article-title":"Detection and visualization of intracutaneous allergic type-specific elements using long-wavelength near-infrared hyperspectral imaging","volume":"19","author":"Nishino","year":"2013","journal-title":"Skin Res Technol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201706000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:11:21Z","timestamp":1695003081000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201706000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000489","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}